MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1158/1078-0432.ccr-05-0999

Медицинская библиотека · Clinical cancer research : an official journal of the American Association for Cancer Research · 2005

Methylation assay for the diagnosis of lung cancer on bronchial aspirates: a cohort study.

Schmiemann Viola, Böcking Alfred, Kazimirek Marietta, Onofre Alexandre Sherlley Casimiro, Gabbert Helmut Erich, Kappes Rainer, Gerharz Claus Dieter, Grote Hans Juergen

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

PURPOSE: Recent studies have detected aberrant promoter methylation of adenomatous polyposis coli promoter 1 A (APC), cyclin-dependent kinase inhibitor-2A (p16(INK4a)), retinoic acid receptor beta2, and RAS association domain family protein 1 (RASSF1A) in bronchial aspirates and suggested their use as biomarkers for lung cancer diagnostics. The purpose of this study was to validate these candidate marker genes in a retrospective cohort study.

EXPERIMENTAL

DESIGN

Bronchial aspirates collected from a cohort comprising 247 patients with suspected lung cancer were investigated retrospectively regarding aberrant promoter methylation using a quantitative methylation-specific real-time PCR (QMSP).

RESULTS

Eighty-nine patients were diagnosed with primary lung cancer, 102 had benign lung disease, and 56 showed miscellaneous other conditions. A panel consisting of APC, p16(INK4a), and RASSF1A emerged as useful combination. This panel detected aberrant methylation in bronchial aspirates of 22 of 35 (63%) and 21 of 44 (44%) centrally and peripherally located primary lung cancers, respectively. Bronchial aspirates also showed aberrant methylation in 5 of 7 (71%) patients with a recurrent lung cancer and in 8 of 30 (27%) cases without tumor recurrence. In contrast, only 1 of 102 patients with benign lung disease displayed a (false) positive test result. Rarely, aberrant methylation was found in patients with other malignancies (3 of 16). The QMSP assay correctly confirmed lung cancer in 8 of 12 (67%) cases with an ambiguous cytology. Moreover, it disclosed 9 of 26 (35%) of peripheral tumors lacking simultaneous cytologic or histologic diagnosis of malignancy.

CONCLUSIONS

Our findings suggest that the QMSP assay could be applied as a reflex test in cases of suspected lung cancer that defy a definite diagnosis by conventional methods. Thus, the assay could be a useful diagnostic adjunct especially regarding peripheral tumors.

Для цитирования: Schmiemann Viola, Böcking Alfred, Kazimirek Marietta, Onofre Alexandre Sherlley Casimiro, Gabbert Helmut Erich, Kappes Rainer, Gerharz Claus Dieter, Grote Hans Juergen. Methylation assay for the diagnosis of lung cancer on bronchial aspirates: a cohort study.. Clinical cancer research : an official journal of the American Association for Cancer Research. 2005. DOI: 10.1158/1078-0432.ccr-05-0999.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.